BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17430104)

  • 1. Formulation of transdermal drug delivery system: matrix type, and selection of polymer- their evaluation.
    Kaza R; Pitchaimani R
    Curr Drug Discov Technol; 2006 Dec; 3(4):279-85. PubMed ID: 17430104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation.
    Aggarwal G; Dhawan S; HariKumar SL
    Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
    Limpongsa E; Umprayn K
    AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride.
    Kusum Devi V; Saisivam S; Maria GR; Deepti PU
    Drug Dev Ind Pharm; 2003 May; 29(5):495-503. PubMed ID: 12779279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
    Akram M; Naqvi SB; Khan A
    Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug.
    Patel NA; Patel NJ; Patel RP
    Drug Dev Ind Pharm; 2009 Feb; 35(2):234-42. PubMed ID: 18785045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel biomaterial for transdermal application: in vitro and in vivo characterization.
    Mundada AS; Avari JG
    Drug Deliv; 2011 Aug; 18(6):424-31. PubMed ID: 21554152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
    Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
    Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D; Michniak-Kohn B
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumatriptan succinate transdermal delivery systems for the treatment of migraine.
    Balaguer-Fernández C; Femenía-Font A; Del Rio-Sancho S; Merino V; López-Castellano A
    J Pharm Sci; 2008 Jun; 97(6):2102-9. PubMed ID: 17854062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
    Babu RJ; Pandit JK
    Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of penetration enhancers on curcumin transdermal drug delivery].
    Gao ZS; Wang L; Zhang M
    Zhong Yao Cai; 2012 Jan; 35(1):141-4. PubMed ID: 22734426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication, evaluation, and enhanced penetration of vinyl and cellulose-engineered transdermal patch of nifedipine using essential oil as penetration enhancer.
    Das S; Das S; Bahadur S; Mukherjee M; Nandi G; Manna S
    J Biomater Sci Polym Ed; 2024 Jun; 35(9):1400-1420. PubMed ID: 38502545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
    Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
    Kumar D; Ali J; Baboota S
    Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
    Rastogi V; Yadav P; Husain A; Verma A
    Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
    Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
    Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.